Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 15;19(2):949.
doi: 10.3390/ijerph19020949.

Trends in Pancreatic Cancer Incidence and Mortality in Lithuania, 1998-2015

Povilas Kavaliauskas  1 , Audrius Dulskas  2   3 , Inga Kildusiene  1 , Rokas Arlauskas  4 , Rimantas Stukas  4 , Giedre Smailyte  1   4
Affiliations

Trends in Pancreatic Cancer Incidence and Mortality in Lithuania, 1998-2015

Povilas Kavaliauskas et al. Int J Environ Res Public Health. .

Abstract

Background: Pancreatic cancer is one of the deadliest cancers worldwide, and its incidence is increasing. The aim of this study was to examine the time trends in the incidence and mortality rates of pancreatic cancer for the period of 1998-2015 for the first time in Lithuania by sex, age, subsite, and stage.

Methods: This study was based on all cases (deaths) of pancreatic cancer diagnosed between 1998 and 2015. Age-standardized incidence (mortality) rates and group-specific rates were calculated for each sex using the direct method (European Standard). TNM classification-based information reported to the cancer registry was grouped into three categories: (1) localized cancer: T1-3/N0/M0; (2) cancer with regional metastasis: any 1-3/N+/M0; (3) advanced cancer: any T/any N/M+. Joinpoint regression was used to provide annual percentage changes (APCs) and to detect points in time where statistically significant changes in the trends occurred.

Results: Overall, 8514 pancreatic cancer cases (4364 in men and 3150 in women) were diagnosed and 7684 persons died from cancer of the pancreas. Pancreatic cancer incidence rates were considerably lower for women than for men, with a female:male ratio of 1:2. Incidence rates changed during the study period from 14.2 in 1998 to 15.0/100,000 in the year 2015 in men, and from 6.7 to 9.8/100,000 in women. Incidence rates over the study period were stable for men (APC = 0.1%) and increasing for women by 1.1% per year. Similarly, mortality rates increased in women by 0.9% per year, and were stable in men. During the study period, incidence and mortality rates of pancreatic cancer were close. For the entire study period, rates increased significantly in the 50-74 years age group; only cancer of the head of pancreas showed a decline by 0.9%, while tail and not-specified pancreatic cancer incidence increased by 11.4% and 4.51%, respectively.

Conclusions: The increasing pancreatic cancer incidence trend in the Lithuanian population may be related to the prevalence of its main risk factors (smoking, obesity, physical inactivity, diet, and diabetes).

Keywords: age-standardized rates; incidence; mortality; pancreatic cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Age-standardized incidence rates of pancreatic cancer by sex in Lithuania from 1998–2015.
Figure 2
Figure 2
Age-standardized mortality rates from pancreatic cancer by sex in Lithuania from 1993–2012.
Figure 3
Figure 3
Age-standardized incidence rates of pancreatic cancer by age group in Lithuania from 1998–2015. Both sexes.
Figure 4
Figure 4
Age-standardized incidence rates of pancreatic cancer by stage of disease in Lithuania from 1998–2015. Both sexes.
Figure 5
Figure 5
Age-standardized incidence rates of pancreatic cancer by subsite in Lithuania from 1998–2015. Both sexes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Global Cancer Observatory. [(accessed on 28 August 2021)]. Available online: https://gco.iarc.fr/
    1. Khalaf N., El-Serag H.B., Abrams H.R., Thrift A.P. Burden of Pancreatic Cancer: From Epidemiology to Practice. Clin. Gastroenterol. Hepatol. 2021;19:876–884. doi: 10.1016/j.cgh.2020.02.054. - DOI - PMC - PubMed
    1. Vincent A., Herman J., Schulick R., Hruban R.H., Goggins M. Pancreatic Cancer. Lancet Lond. Engl. 2011;378:607–620. doi: 10.1016/S0140-6736(10)62307-0. - DOI - PMC - PubMed
    1. Cameron J.L., Riall T.S., Coleman J., Belcher K.A. One Thousand Consecutive Pancreaticoduodenectomies. Ann. Surg. 2006;244:10–15. doi: 10.1097/01.sla.0000217673.04165.ea. - DOI - PMC - PubMed
    1. Bray F., Ferlay J., Laversanne M., Brewster D.H., Gombe Mbalawa C., Kohler B., Piñeros M., Steliarova-Foucher E., Swaminathan R., Antoni S., et al. Cancer incidence in five continents: Inclusion criteria, highlights from volume X and the global status of cancer registration. Int. J. Cancer. 2015;137:2060–2071. doi: 10.1002/ijc.29670. - DOI - PubMed